Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
RAB2A - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
CYP4V2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
HAUS1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
CENPN - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
CYB5B - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
EZH2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
ERV3-2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GEO DataSets Gene Profile neighbors
Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GEO DataSets Profile neighbors
LOC153684 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GEO DataSets Gene Profile neighbors Chromosome neighbors
TMEM170A - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
ACTR3 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
CCL2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
H2AFV - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
TP53INP1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
PHACTR2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
CHD6 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on